RecruitingNot ApplicableNCT02551068

High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

High Oxygen Delivery to Preserve Exercise Capacity in IPF Patients Treated With Nintedanib: The HOPE-IPF Study


Sponsor

University of British Columbia

Enrollment

88 participants

Start Date

Dec 1, 2015

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose is to determine if patients with idiopathic pulmonary fibrosis (IPF) taking nintedanib will have improved exercise endurance, breathlessness and quality of life if breathing 60% oxygen compared to standard of care during an 8 week exercise training program.


Eligibility

Min Age: 19 Years

Inclusion Criteria7

  • Age 19 years or older
  • Idiopathic Pulmonary Fibrosis (IPF) diagnosis according to American Thoracic Society and/or European Respiratory Society consensus criteria
  • Appropriate candidate for pulmonary rehabilitation
  • prescribed nintedanib by their treating physician or currently on nintedanib
  • minute walk distance 50m or more
  • Oxygen saturation 92% or more by pulse oximetry at rest while breathing room air
  • Clinically stable for the preceding 6 weeks

Exclusion Criteria8

  • Contraindication to treatment with nintedanib (based on Canadian labeling)
  • Contraindication to exercise testing (e.g. significant cardiovascular, musculoskeletal, neurological disease)
  • Other significant extra-pulmonary disease that, based on clinical assessment, could impair exercise capacity and/or oxygenation
  • Forced vital capacity (FVC) less than 50% or Diffusion capacity for carbon monoxide (DLCO) less than 25%
  • Concurrent or recent participation (less than 6 months) in a pulmonary rehabilitation program
  • Use of prednisone greater than 10 mg/day for more than 2 weeks within 3 months of the first study visit
  • Use of pirfenidone within 4 weeks of screening
  • Significant emphysema (less than 10% volume on high resolution computed tomography (HRCT) or forced expiratory volume at one second (FEV1)/FVC less than 0.70)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER60% Oxygen

While participants are exercising, they will be inhaling 60% oxygen through a mask

OTHERStandard of Care

While participants are exercising, they will be breathing air through a mask that will be titrated to keep oxygen saturation at least 88%, allowing a maximum inhaled oxygen percentage of 40%.


Locations(8)

University of Calgary

Calgary, Alberta, Canada

University of Alberta

Edmonton, Alberta, Canada

UBC Okanagan

Kelowna, British Columbia, Canada

St. Paul's Hospital

Vancouver, British Columbia, Canada

McMaster University

Hamilton, Ontario, Canada

Queens University

Kingston, Ontario, Canada

McGill University

Montreal, Quebec, Canada

Laval University

Québec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02551068


Related Trials